false
OasisLMS
Catalog
SCCM Resource Library
Rationale for Beta-Blocker Use in Shock
Rationale for Beta-Blocker Use in Shock
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
Brittany's presentation focuses on the physiologic rationale behind using beta blockers in sepsis treatment, emphasizing the importance of understanding beta receptor mechanisms. She highlights key factors affecting beta blocker efficacy, including patient history and underlying conditions, and discusses beta-1 and beta-2 receptors' roles in physiological processes. Beta blockers can potentially modulate metabolic dysfunction, thrombogenicity, cardiomyopathy, and immunosuppression during septic shock. Brittany clarifies beta blockers' competitive inhibition at adrenergic receptors and their influence on the sympathetic nervous system's stress response through catecholamine pathophysiology. She outlines the potential benefits of beta-1 blockade, such as improved myocardial function, versus varied effects of beta-2 blockade. Future treatment may benefit from personalized approaches due to complexities in immune response and receptor dynamics. Despite new clinical evidence, Brittany underlines the need for continued research to unravel the complexities of beta blockers in septic patients.
Asset Caption
One-Hour Concurrent Session | Flipping the Script: Beta-Blockers in Shock
Meta Tag
Content Type
Presentation
Membership Level
Professional
Membership Level
Select
Year
2024
Keywords
beta blockers
sepsis treatment
adrenergic receptors
catecholamine pathophysiology
personalized medicine
×
Please select your language
1
English